Bacterial vaginosis during pregnancy may lead to increased risks for preterm birth, preterm delivery, and spontaneous abortion, according to new research in the Archives of Gynecology and Obstetrics.
Bacterial vaginosis during pregnancy may lead to adverse outcomes, such as preterm birth, preterm delivery, and spontaneous abortion, according to results from a meta-analysis.
Researchers conducted a meta-analysis to delve deeper into the connection between bacterial vaginosis in early pregnancy and preterm birth. From November 2018 to March 2020, they searched PubMed, Cochrane, Google Scholar, and LILAC for data relating to bacterial vaginosis and preterm birth. They only included studies that were published from 2008 to 2018 and those that offered statistical data. They excluded studies that only consisted of conceptual and qualitative data. The search ultimately led to data from 20,894 women across 11 studies.
Researchers then evaluated the findings of each study, extracting various outcomes and conclusions. They combined the results—risk ratios (RR) and odds ratios (OR)—for deeper analysis. For women with bacterial vaginosis during pregnancy, the combined odds of preterm birth or preterm delivery was 2.79 (2.29-3.41).
Through their evaluation, they found that preterm birth was more than 2 times as likely in pregnant women with bacterial vaginosis than those without the infection (OR= 2.79; 95% CI, 2.29 to 3.41). Bacterial vaginosis was also found to be a greater risk factor for preterm delivery in late pregnancy, increasing the odds 4-fold.
Researchers also examined the conclusions of each study, ultimately identifying bacterial vaginosis in early pregnancy as a significant risk factor for preterm delivery and spontaneous abortion. They also found that the administration of clindamycin at <22 weeks’ gestation significantly reduced the risk for preterm birth.
Reference
Mohanty T, Doke PP, Khuroo SR. Effect of bacterial vaginosis on preterm birth: a meta-analysis [published online ahead of print, 2022 Oct 17]. Arch Gynecol Obstet. 2022;10.1007/s00404-022-06817-5. doi:10.1007/s00404-022-06817-5
Expert consensus sheds light on diagnosis and management of vasa previa
December 5th 2024A recent review established guidelines for prenatal diagnosis and care of vasa previa, outlining its definition, screening and diagnosis, management, and timing of delivery in asymptomatic patients.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Cesarean delivery reduces mortality risk in preterm breech births
December 2nd 2024In a recent study, infants born very preterm or extremely preterm had reduced odds of mortality when cesarean delivery was chosen as the mode of delivery, without a notable increase in any morbidity risk.
Read More
Maternal sFLT1 and EDN1 linked to late-onset preeclampsia
November 25th 2024A new study highlights the association of maternal soluble Fms-like tyrosine kinase 1 and endothelin 1 with preeclampsia severity, offering insights into the pathogenesis of early- and late-onset forms of the condition.
Read More
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More